NEM

Newmont (NEM) Is Up - What Are Investors Seeing in This Stock?

Newmont stock is trading -46.23% below its average target price of $78.42 after marking a 1.4% during today's afternoon session. Analysts are giving the large-cap Silver company an average rating of hold and target prices ranging from $58.22 to $94.35 per share.

Newmont's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 2.9%. The stock's short ratio is 2.42. The company's insiders own 0.11% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Another number to watch is the company's rate of institutional share ownership, which now stands at 81.6%. In conclusion, we believe there is mixed market sentiment regarding Newmont.

Institutions Invested in Newmont

Date Reported Holder Percentage Shares Value
2023-03-31 Blackrock Inc. 12% 95,023,960 $4,007,160,219
2023-03-31 Vanguard Group, Inc. (The) 9% 70,142,382 $2,957,904,120
2023-03-31 State Street Corporation 5% 40,231,950 $1,696,581,257
2023-03-31 Van Eck Associates Corporation 4% 33,949,248 $1,431,639,725
2023-03-31 First Eagle Investment Management, LLC 2% 18,430,298 $777,205,632
2023-03-31 Deutsche Bank Aktiengesellschaft 2% 17,968,912 $757,748,986
2023-03-31 Charles Schwab Investment Management, Inc. 2% 15,728,029 $663,250,954
2023-03-31 FMR, LLC 2% 14,718,524 $620,680,130
2023-03-31 Geode Capital Management, LLC 2% 14,289,705 $602,596,833
2023-03-31 Flossbach von Storch AG 2% 13,892,539 $585,848,344
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS